CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...

The ArteraAI Prostate Test (mHSPC) is the first externally developed digital pathology algorithm being made clinically available through the Tempus ecosystem. This AI-powered test assesses a patient's ...

Doctors and scientists around the world are constantly searching for better ways to treat cancer. The goal is not only to help people live longer, but also to reduce side effects and improve quality ...

The diagnostic period itself may have a significant psychological impact. Qualitative interviews with men undergoing active surveillance for low-risk disease described an “emotional diagnostic ...

New capability enables more precise prostate cancer detection, a major advancement for men's health across Idaho No one ...

A new cancer treatment center, Southwest Florida Proton, has opened in Estero. The center offers proton therapy, a preferred ...

Key Points Interested in Candel Therapeutics, Inc.? Here are five stocks we like better. Candel Therapeutics said it remains ...